- What is TMS Therapy®?
- NeuroStar® Clinical Research
- NeuroStar TMS Therapy® System
- NeuroStar® Service & Support
- Reimbursement Support
- NeuroStar® Resources
- Contact Us
NeuroStar TMS Therapy® System
The NeuroStar TMS Therapy System is the first and only TMS device cleared by the U.S. Food and Drug Administration (FDA) to treat patients with Major Depressive Disorder (MDD) who have not benefited from initial antidepressant treatment.* This breakthrough depression treatment uses a highly focused, pulsed magnetic field, similar in type and strength to those produced by a magnetic resonance imaging (MRI) machine, to stimulate function in brain regions known to affect mood. The NeuroStar TMS Therapy System utilizes several unique patented technologies to maximize patient treatments:
- SenStar® Treatment Link – The link to safe, effective and tolerable treatment
- MT Assist® – Unique software makes finding the right treatment dose easy
- Precision Pulse TMS™ Technology – Patented coil design improves efficiency which increases patient throughput
- Coil Positioning System – Integrated positioning system assures repeatable and accurate treatment.
- TMS TrakStar™ – Proprietary patient database that facilitates TMS reporting and documentation
The NeuroStar® System was designed for therapeutic use. To guide our customers in establishing and operating a successful TMS clinic, Neuronetics provides all key system components and software as well as clinical training and services as part of the cost of the NeuroStar TMS Therapy System.
Indication
*NeuroStar TMS Therapy® is an FDA-cleared, non-drug treatment for patients with depression who have not benefitted from one prior antidepressant medication. NeuroStar TMS Therapy is available by prescription only. Only a doctor can help decide if NeuroStar TMS Therapy is right for you.
Click Here for Full Safety and Prescribing Information